| A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy (NCT02522234) | EVIVE Biotechnology | 2014-02-25 |
| Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers (NCT02020707) | Mayo Clinic | 2014-02-24 |
| A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021) (NCT02039674) | Merck Sharp & Dohme LLC | 2014-02-21 |
| Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery (NCT01854684) | Roswell Park Cancer Institute | 2014-02-21 |
| Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers (NCT02045264) | Shire | 2014-02-21 |
| Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease (NCT01950507) | National Institutes of Health Clinical Center (CC) | 2014-02-20 |
| Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers (NCT01113515) | Novalead Pharma Private Limited | 2014-02-20 |
| Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination (NCT02064504) | GlaxoSmithKline | 2014-02-19 |
| Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State (NCT02052713) | GlaxoSmithKline | 2014-02-19 |
| Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects (NCT02080468) | Aegerion Pharmaceuticals, Inc. | 2014-02-19 |
| A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma (NCT01998971) | Janssen Research & Development, LLC | 2014-02-18 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28) (NCT02054806) | Merck Sharp & Dohme LLC | 2014-02-17 |
| Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers (NCT03826719) | SK Chemicals Co., Ltd. | 2014-02-17 |
| Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study (NCT02091921) | University of Southern California | 2014-02-16 |
| Phase 1 Trial of CXD101 in Patients With Advanced Cancer (NCT01977638) | Oxford University Hospitals NHS Trust | 2014-02-14 |
| A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023) (NCT02036502) | Merck Sharp & Dohme LLC | 2014-02-14 |
| Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients (NCT02064569) | GenSight Biologics | 2014-02-13 |
| Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection (NCT02637999) | Hepatera Ltd. | 2014-02-13 |
| Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT (NCT03963024) | IRCCS San Raffaele | 2014-02-12 |
| Ferumoxytol-enhanced Imaging of Osteomyelitis (NCT05959590) | University of New Mexico | 2014-02-12 |
| Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State (NCT02058576) | GlaxoSmithKline | 2014-02-11 |
| A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia (NCT02028455) | Seattle Children's Hospital | 2014-02-11 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005) (NCT02059174) | Merck Sharp & Dohme LLC | 2014-02-10 |
| A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers. (NCT02019290) | Hoffmann-La Roche | 2014-02-10 |
| First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors (NCT04577703) | Sunshine Lake Pharma Co., Ltd. | 2014-02-08 |
| T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive (NCT02111850) | National Cancer Institute (NCI) | 2014-02-07 |
| Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis (NCT02054572) | Amgen | 2014-02-07 |
| A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia (NCT02011945) | Bristol-Myers Squibb | 2014-02-07 |
| Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR) (NCT02054351) | Ganymed Pharmaceuticals GmbH | 2014-02-06 |
| Donor-Derived Viral Specific T-cells (VSTs) (NCT02048332) | Children's Hospital Medical Center, Cincinnati | 2014-02-05 |
| Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy (NCT01922921) | University of Washington | 2014-02-05 |
| Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib (NCT02040480) | GlaxoSmithKline | 2014-02-05 |
| Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjects (NCT02060266) | Novo Nordisk A/S | 2014-02-04 |
| Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations (NCT01989546) | National Cancer Institute (NCI) | 2014-02-04 |
| Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma (NCT02034123) | GlaxoSmithKline | 2014-02-04 |
| SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease. (NCT02036645) | AstraZeneca | 2014-02-04 |
| Effect of Mixed On-line Hemodiafiltration on Circulating Markers of Inflammation and Vascular Dysfunction (NCT03202212) | A.O.U. Città della Salute e della Scienza | 2014-02-03 |
| A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions (NCT02201316) | GlaxoSmithKline | 2014-02-03 |
| Remifentanil for General Anesthesia in the Context of Immaturity (NCT02029898) | University Hospital, Rouen | 2014-02-02 |
| Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression (NCT02914769) | Universidade Federal do Rio Grande do Norte | 2014-02-01 |
| A Study Evaluating the Effect of Formulation on the Bioavailability of Ipatasertib in Healthy Volunteers (NCT02063581) | Genentech, Inc. | 2014-02-01 |
| Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors (NCT02071888) | Calithera Biosciences, Inc | 2014-02-01 |
| A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma (NCT02043899) | Cancer Research UK | 2014-02-01 |
| A Study to Assess the Effect of Food on the Bioavailability of Mebendazole From a Fast-Disintegrating Chewable Formulation of Mebendazole in Healthy Participants (NCT02051738) | Janssen Research & Development, LLC | 2014-02-01 |
| Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine Transdermal Patch Comparing 2 Different Formulations (NCT02070796) | UCB Pharma SA | 2014-02-01 |
| First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration (NCT02076919) | Alcon Research | 2014-02-01 |
| Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe (NCT02029625) | NVP Healthcare | 2014-02-01 |
| To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers (NCT02046850) | AstraZeneca | 2014-02-01 |
| Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress (NCT02058251) | Medical University of South Carolina | 2014-02-01 |
| TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer (NCT01455389) | Genprex, Inc. | 2014-02-01 |
| Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD) (NCT01708278) | University of Michigan | 2014-02-01 |
| Gastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver Transplantation (NCT02068872) | Northwestern University | 2014-02-01 |
| An Open-label, Single-dose Study to Determine the Metabolism and Excretion of [14C]E2006 in Healthy Male Subjects (NCT02046213) | Eisai Inc. | 2014-02-01 |
| A Study to Determine the Effect of a High-Fat Meal on the Rate and Extent of E2006 Absorption in Healthy Subjects (NCT02089412) | Eisai Inc. | 2014-02-01 |
| Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male Subjects (NCT02075073) | Samsung Bioepis Co., Ltd. | 2014-02-01 |
| Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients (NCT02089919) | Fuda Cancer Hospital, Guangzhou | 2014-02-01 |
| PK Study of Pregabalin GLARS Tablet 150mg and IR Formulation After Multiple Dosing Under Fed Condition in Healthy Male Subjects (NCT01638273) | GL Pharm Tech Corporation | 2014-02-01 |
| Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) (NCT01895842) | M.D. Anderson Cancer Center | 2014-02-01 |
| CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) (NCT02047175) | Chong Kun Dang Pharmaceutical | 2014-02-01 |
| Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors (NCT02063958) | Esanex Inc. | 2014-02-01 |
| Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone (NCT02305316) | Bial - Portela C S.A. | 2014-02-01 |
| Phase I Study of Chiauranib in Patients With Advanced Solid Tumors (NCT02122809) | Chipscreen Biosciences, Ltd. | 2014-02-01 |
| Study of the Glutaminase Inhibitor CB-839 in Solid Tumors (NCT02071862) | Calithera Biosciences, Inc | 2014-02-01 |
| Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis (NCT02060305) | National Taiwan University Hospital | 2014-02-01 |
| Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients (NCT01974258) | Hoffmann-La Roche | 2014-02-01 |
| MARY DUOL REPAIR BALM IN THE PREVENTION OR REDUCING ANTINEOPLASIC AGENTS' SKIN TOXICITY (NCT02036957) | Basque Health Service | 2014-02-01 |
| Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. (NCT02012231) | Fore Biotherapeutics | 2014-02-01 |
| TD-6450 SAD and MAD in Healthy Subjects (NCT02022306) | Theravance Biopharma | 2014-02-01 |
| Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence (NCT02034201) | University of Arkansas | 2014-02-01 |
| Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma (NCT02030483) | Weill Medical College of Cornell University | 2014-02-01 |
| Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma (NCT01952769) | Hadassah Medical Organization | 2014-02-01 |
| Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects (NCT02073812) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2014-02-01 |
| Hyperthermia and Proton Therapy in Unresectable Soft Tissue Sarcoma (NCT01904565) | Kantonsspital Aarau | 2014-02-01 |
| Phase I/Ib Clinical Trial of ABTL0812 in Advanced Cancer Patients (NCT02201823) | Ability Pharmaceuticals SL | 2014-02-01 |
| CO as a Stimulant for Mitochondrial Biogenesis in Human Cardiac Muscle (NCT01727167) | John J Freiberger | 2014-02-01 |
| Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD (NCT02022540) | PanOptica, Inc. | 2014-02-01 |
| MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects (NCT02013388) | Nivalis Therapeutics, Inc. | 2014-02-01 |
| A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis (NCT01975688) | GW Pharmaceuticals Ltd | 2014-02-01 |
| A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis (NCT02058264) | Botanix Pharmaceuticals | 2014-02-01 |
| Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia (NCT02078310) | Intra-Cellular Therapies, Inc. | 2014-02-01 |
| Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (NCT01746784) | Nivalis Therapeutics, Inc. | 2014-02-01 |
| A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion (NCT02085967) | Eisai Inc. | 2014-02-01 |
| Phase 1/2a Study on Allogeneic Osteoblastic Cells Implantation in Delayed-Union Fractures (NCT02020590) | Bone Therapeutics S.A | 2014-02-01 |
| Filling Bone Defects/Voids With Autologous BonoFill For Maxillofacial Bone Regeneration (NCT02153268) | BonusBio Group Ltd | 2014-02-01 |
| Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML (NCT02076191) | John Mascarenhas | 2014-02-01 |
| H-Side Branch Stent, A New Stent for the Treatment of True Bifurcation Lesions (NCT02037386) | Yonsei University | 2014-02-01 |
| A Phase I, Prospective, Randomized, Open-label, Active-Controlled Clinical Trial for Safety Evaluation of Intra-articular Injection of RegenoGel-SP for the Treatment of Moderate to Severe Osteoarthritis (NCT02188771) | ProCore Ltd. | 2014-02-01 |
| A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects (NCT02113020) | Takeda | 2014-02-01 |
| A Cross-over Study Examining the Bioequivalence of 3 Test Formulations to a Reference Formulation of Alectinib (RO5424802) in Healthy Volunteers (NCT02074553) | Hoffmann-La Roche | 2014-02-01 |
| A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF) (NCT02069119) | Otsuka Pharmaceutical Co., Ltd. | 2014-02-01 |
| Umbilical Cord Mesenchymal Stem Cells Injection for Peripheral Arterial Disease (NCT02287831) | Institute of Hematology & Blood Diseases Hospital, China | 2014-02-01 |
| Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect. (NCT02334709) | University Hospital, Ghent | 2014-02-01 |
| Safety Study of APD-791 With Aspirin and/or Clopidogrel (NCT02034292) | IlDong Pharmaceutical Co Ltd | 2014-02-01 |
| Kinesio Taping Effects Applied With Different Directions and Tensions (NCT02501915) | Universidade Estadual de Goiás | 2014-02-01 |
| Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer (NCT02109341) | Gruppo Oncologico Italiano di Ricerca Clinica | 2014-02-01 |
| Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers (NCT02091310) | Genfit | 2014-02-01 |
| Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets (NCT03056703) | Bayer | 2014-02-01 |
| Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia (NCT01845727) | Drugs for Neglected Diseases | 2014-02-01 |
| Patients With Brain Metastases From HER2-positive Breast Cancer (NCT02135159) | Institut du Cancer de Montpellier - Val d'Aurelle | 2014-02-01 |
| Pilot Study of OXP001 and Brufen in Healthy Subjects (NCT02050958) | Oxford Pharmascience Ltd | 2014-02-01 |